Literature DB >> 15817955

Hepatitis B & hepatitis C in HIV-infection.

Shyam Kottilil1, Julia O Jackson, Michael A Polis.   

Abstract

Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are the three most common chronic viral infections seen in the world. All three viruses share modes of transmission and hence co-exist in the same host at significantly high rates. HIV-induced immunosuppression has deleterious effects on the natural history, pathophysiology, diagnosis, therapeutic responses to hepatitis viruses. Responses to HBV vaccination are impaired in persons with HIV infection. Co-infection with the hepatitis viruses and HIV is likely to become a major health care catastrophe in the coming years. This review discusses the current trends in the understanding of the biology of co-infection and implications for treating these viruses effectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817955

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  4 in total

Review 1.  Hepatitis B virus vaccination in HIV-infected people: A review.

Authors:  François-Xavier Catherine; Lionel Piroth
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

2.  Comparison of the abbott 7000 and bayer 340 systems for measurement of hepatitis C virus load.

Authors:  Helene C Highbarger; Zonghui Hu; Shyam Kottilil; Julia A Metcalf; Michael A Polis; M B Vasudevachari; H Clifford Lane; Robin L Dewar
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

3.  Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa.

Authors:  Euphodia Makondo; Trevor G Bell; Anna Kramvis
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

4.  Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis.

Authors:  Yakun Tian; Wei Hua; Yaxin Wu; Tong Zhang; Wen Wang; Hao Wu; Caiping Guo; Xiaojie Huang
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.